Request Demo
Last update 23 Jan 2025
GRT-6010
Last update 23 Jan 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism OOR agonists(Nociceptin receptor agonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
4
Clinical Trials associated with GRT-6010EUCTR2016-003940-35-DE
Exploratory, randomized, double-blind, placebo-controlled evaluation of efficacy, tolerability, and safety of intravesical instillation of GRT6010 compared to placebo in subjects with bladder pain syndrome
NL-OMON37607
A randomized, single-center, double-blind, placebo-controlled, 2-way cross-over, single oral administration trial to evaluate blood-borne biomarker candidates to predict NOP receptor activation using GRT6010 as NOP receptor agonist in healthy human subjects. - Evaluation biomarker to predict NOP receptor activation using GRT6010
EUCTR2011-002092-42-DE
Evaluation of the efficacy, tolerability, and safety of 7 days of treatment with GRT6010 or pregabalin in comparison to placebo in subjects with peripheral neuropathic pain.
100 Clinical Results associated with GRT-6010
Login to view more data
100 Translational Medicine associated with GRT-6010
Login to view more data
100 Patents (Medical) associated with GRT-6010
Login to view more data
100 Deals associated with GRT-6010
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetic peripheral neuropathic pain | Phase 2 | PL | 01 Feb 2012 | |
| Diabetic peripheral neuropathic pain | Phase 2 | GB | 01 Feb 2012 | |
| Diabetic peripheral neuropathic pain | Phase 2 | HU | 01 Feb 2012 | |
| Diabetic peripheral neuropathic pain | Phase 2 | DE | 01 Feb 2012 | |
| Neuralgia | Phase 2 | PL | 01 Feb 2012 | |
| Neuralgia | Phase 2 | GB | 01 Feb 2012 | |
| Neuralgia | Phase 2 | DE | 01 Feb 2012 | |
| Neuralgia | Phase 2 | HU | 01 Feb 2012 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 2 | 114 | Matching Placebo (Matching Placebo) | prqkyytpiu(izsnvntcrq) = fsfyghuiis iccsxivkqh (hhywfqhccn, urfhisearp - zwyzvpygkb) View more | - | 02 Oct 2014 | ||
(GRT6010) | prqkyytpiu(izsnvntcrq) = xzdkxgicsy iccsxivkqh (hhywfqhccn, knflbtrdfi - ynwgcbdwus) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free